Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Nanobiotechnology

Sequencing at the end of the tunnel

Electron tunnelling can be used to identify single bases in a short DNA oligomer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Interrogation of individual DNA bases by electron tunnelling.

References

  1. Schloss, J. A. Nature Biotechnol. 26, 1113–1115 (2008).

    Article  CAS  Google Scholar 

  2. Zwolak, M. & Di Ventra, M. Rev. Mod. Phys. 80, 141–165 (2008).

    Article  Google Scholar 

  3. Branton, D. et al. Nature Biotechnol. 26, 1146–1153 (2008).

    Article  CAS  Google Scholar 

  4. Zwolak, M. & Di Ventra, M. Nano Lett. 5, 421–424 (2005).

    Article  CAS  Google Scholar 

  5. Lagerqvist, J., Zwolak, M. & Di Ventra, M. Nano Lett. 6, 779–782 (2006).

    Article  CAS  Google Scholar 

  6. Tsutsui, M., Taniguchi, M., Yokota, K. & Kawai, T. Nature Nanotech. 5, 286–290 (2010).

    Article  CAS  Google Scholar 

  7. Chang, S. et al. Nano Lett. 10, 1070–1075 (2010).

    Article  CAS  Google Scholar 

  8. Huang, S. et al. Nature Nanotech. 10.1038/nnano.2010.213 (2010).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Ventra, M. Sequencing at the end of the tunnel. Nature Nanotech 5, 828–829 (2010). https://doi.org/10.1038/nnano.2010.238

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2010.238

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research